Robert Shrewsbury
Document Actions
1. Biopharmaceutics Review Branch, Food and Drug Administration, Washington, D.C. Monograph Preparation, "Bioavailability and Bioequivalence of Sodium Sulfoxone," 1975, Consultant.
2. Biomedical Research Grant, The Jewish Hospital of Washington University, St. Louis, Missouri, "Study of Intravenous Quinidine Gluconate in the Treatment of Major Ventricular Dysrhythmias During the Acute Phase of Myocardial Infarction," 1980-1982, Investigator.
3. University Research Council Grant, University of North Carolina at Chapel Hill, "Effect of Calcium Chelators on Gastrointestinal Membranes: Possible Mechanism of GI Distress," 1980-1982, Principal Investigator.
4. University Research Council Grant, University of North Carolina at Chapel Hill, "Mechanism of the Alteration in Gastrointestinal Membrane Caused by Disodium Etidronate (EHDP)," 1981-1983, Principal Investigator.
5. Fisons Limited, Loughborough, England, "Disposition of Topically Applied Sodium Cromoglycate in the Albino Rabbit Eye," 1982-1983, Investigator.
6. University Research Council Grant, University of North Carolina at Chapel Hill, "Evaluation of Potential Pro-drug Esters of Chloramphenicol," 1983-1985, Principal Investigator.
7. University Research Council Grant, University of North Carolina at Chapel Hill, "The Effect of Perfluorochemicals on the Pharmacokinetics of Model Drugs," 1984-1986, Principal Investigator.
8. Burroughs Wellcome Company, Research Triangle Park, North Carolina, "Collaborative Research Projects in Pharmacokinetics," 1984-1985, Principal Investigator.
9. National Heart, Lung, and Blood Institute, National Institutes of Health, "Effect of Perfluorochemical Exchange on Drug Kinetics," 1984-1987, Principal Investigator.
10. IBM Institutional Development Foundation Award, University of North Carolina at Chapel Hill, "Influence of Perfluorochemical Emulsion-Blood Exchange on the Pharmacokinetics of Select Drugs," 1985, Principal Investigator.
11. National Heart, Lung, and Blood Institute, National Institutes of Health, "Antihyperlipidemic Phthalimide Analogues," 1986-1989, Investigator.
12. Biomedical Research Support Grant, National Institutes of Health, "Effect of Perfluorochemical Emulsion Hemodilution on Drug Kinetics," 1988-1989, Principal Investigator.
13. EPA Cooperative Clinical Research Agreement, Environmental Protection Agency and the University of North Carolina at Chapel Hill Center for Environmental Medicine, "Collaborative Clinical Research on the Health Effects of Exposure to Air Pollutants," 1990-1995, Pharmacokinetics Consultant.
14. Small Business Innovation Research Program, Phase II, Department of Energy, "Novel Base Oligonucleotides for Boron Neutron Capture," 1990-1992, Investigator.
15. Small Business Innovation Research Program, Phase II, National Institutes of Health, "Oligonucleotides with Boronated Phosphorus Backbones," 1991-1993, Investigator.
16. Small Business Innovation Research Program, Phase II, Department of Energy, "New Boron Containing Amino Acids and Peptides for Boron Neutron Capture Therapy," 1991-1993, Investigator.
17. Small Business Innovation Research Program, Phase I, National Institutes of Health, "Amine-boranes as New Topoisomerase II Inhibitors," 1993, Investigator.
18. Faculty Seed Grant Program, University of North Carolina at Chapel Hill School of Pharmacy, "Pharmacokinetics of Oligonucleotides," 1993-1994, Principal Investigator.
19. Small Business Innovation Research Program, Phase II, National Institutes of Health, "Nucleoside Phosphate Analogues with Boronated Phosphates," 1993-1994, Investigator.
20. Small Business Innovation Research Program, Phase II, Department of Energy, "New Gadolinium-Boron Compounds for Neutron Capture Therapy," 1993-1995, Consultant.
21. Chancellor’s Task Force on Instructional Technology, University of North Carolina at Chapel Hill, "Initiating an Internet-Based External PharmD Curriculum," 1996-1997, Principal Investigator.
22. Program of Excellence in Pharmaceutical Care Grant, School of Pharmacy, University of North Carolina at Chapel Hill, "Syndectic Technology: A Hybrid CD-Internet Delivery System for On Campus and Distance Education," 1997-1999, Principal Investigator.
23. UNC-IBM Curricular Innovation Technology Grant, University of North Carolina at Chapel Hill, "Development of a Socratic Method ‘Patient Simulation’ Prototype," 2001-2002, Principal Investigator.